Dan Lu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Dan Lu has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
Linyuan Fan
Capital Med Univ, Beijing Obstet & Gynecol Hosp, Beijing Maternal & Child Hlth Care Hosp, Dept Gynecol, Beijing 100026, Peoples R China
3 shared publications- Yong Liu
Department of Gynecology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, 100026 Beijing, China
3 shared publications Chang Lu
Department of Gynecology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, China
2 shared publicationsChengmao Xie
Department of Gynecology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, Beijing, China
2 shared publicationsJian Ren
Department of Gynecology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, 100026 Beijing, China
2 shared publicationsLingge Jin
Department of Gynecology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, 100026 Beijing, China
2 shared publications
Latest Publications
- Open Access
- 1 April 2024
- Published by China Science Publishing & Media Ltd. in Acta Biochimica et Biophysica Sinica
- Vol. 56 (6) , 952-955
Integrated analysis of endometrial stromal cell long noncoding RNA and mRNA expression profiles associated with TGF-β1-induced fibrosis
- 1 April 2024
- Published by China Science Publishing & Media Ltd. in Acta Biochimica et Biophysica Sinica
- Vol. 56 (6) , 952-955
Open AccessIntegrated analysis of endometrial stromal cell long noncoding RNA and mRNA expression profiles associated with TGF-β1-induced fibrosis
- 28 January 2024
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 294, 198-205
Implication of androgen receptor gene dysfunction in human Müllerian duct anomalies
- 28 January 2024
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 294, 198-205
Implication of androgen receptor gene dysfunction in human Müllerian duct anomalies
- Open Access
- 8 June 2023
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 28 (6) , 109
The Role of Long Noncoding RNAs in Endometriosis Progression
Endometriosis (EMs) is a common gynecological disease with an increasing incidence in recent years. Because of the lack of specific molecular biological indicators in clinical practice, diagnosis is often delayed and the quality of life of patients is seriously reduced. Therefore, the discovery of effective molecular biomarkers is crucial for the early diagnosis and treatment of EMs patients. With the development of high-throughput sequencing technology, the mechanism of lncRNAs in EMs has been increasingly confirmed experimentally. This article summarizes the biological characteristics and functions of EMs-related lncRNAs, and introduces the mechanisms of EMs-related lncRNAs in the context of ceRNAs, in exosomes, under hypoxic conditions, and related antisense RNAs. The mechanism of the most popular imprinted gene H19 and metastasis-associated lung adenocarcinoma transcript 1 in EMs is then introduced. Finally, we explore the challenges of molecular biomarker EMs-related lncRNAs in the diagnosis and treatment of EMs, anticipating their potential value in clinical applications.
- 8 June 2023
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 28 (6) , 109
Open AccessThe Role of Long Noncoding RNAs in Endometriosis Progression
Endometriosis (EMs) is a common gynecological disease with an increasing incidence in recent years. Because of the lack of specific molecular biological indicators in clinical practice, diagnosis is often delayed and the quality of life of patients is seriously reduced. Therefore, the discovery of effective molecular biomarkers is crucial for the early diagnosis and treatment of EMs patients. With the development of high-throughput sequencing technology, the mechanism of lncRNAs in EMs has been increasingly confirmed experimentally. This article summarizes the biological characteristics and functions of EMs-related lncRNAs, and introduces the mechanisms of EMs-related lncRNAs in the context of ceRNAs, in exosomes, under hypoxic conditions, and related antisense RNAs. The mechanism of the most popular imprinted gene H19 and metastasis-associated lung adenocarcinoma transcript 1 in EMs is then introduced. Finally, we explore the challenges of molecular biomarker EMs-related lncRNAs in the diagnosis and treatment of EMs, anticipating their potential value in clinical applications.
- Open Access
- 13 March 2023
- Published by Springer Nature in BMC Women's Health
- Vol. 23 (1) , 1-9
PCGEM1 promotes cell proliferation and migration in endometriosis by targeting miR-124-3p-mediated ANTXR2 expression
Background: Endometriosis, a common gynaecological disease in women, affects 10% of women of childbearing age. Among infertile women, this proportion is as high as 30–50%. Despite the high prevalence of endometriosis, the pathogenesis of endometriosis is still unclear. Methods: In the present study, bioinformatics analysis and molecular and animal experiments were employed to explore the functions of PCGEM1 in the pathogenesis of endometriosis. We established an endometriosis rat model and isolated endometrial stromal cells (ESCs) and primary normal ESCs (NESCs). Bioinformatics analysis was adopted to study the roles of PCGEM1 in promoting the pathogenesis of endometriosis. Luciferase reporter assays and RNA pull-down assays were carried out to study the mechanism by which PCGEM1 regulates ANTXR2. Results: Our results indicated that PCGEM1 promoted the motility and proliferation of ectopic endometrial cells, and the underlying mechanism was due to the direct binding of PCGEM1 to miR-124-3p to modulate ANTXR2 expression. Conclusion: PCGEM1 can influence endometrial stromal cell proliferation and motility and may be a novel therapeutic target for endometriosis.
- 13 March 2023
- Published by Springer Nature in BMC Women's Health
- Vol. 23 (1) , 1-9
Open AccessPCGEM1 promotes cell proliferation and migration in endometriosis by targeting miR-124-3p-mediated ANTXR2 expression
Background: Endometriosis, a common gynaecological disease in women, affects 10% of women of childbearing age. Among infertile women, this proportion is as high as 30–50%. Despite the high prevalence of endometriosis, the pathogenesis of endometriosis is still unclear. Methods: In the present study, bioinformatics analysis and molecular and animal experiments were employed to explore the functions of PCGEM1 in the pathogenesis of endometriosis. We established an endometriosis rat model and isolated endometrial stromal cells (ESCs) and primary normal ESCs (NESCs). Bioinformatics analysis was adopted to study the roles of PCGEM1 in promoting the pathogenesis of endometriosis. Luciferase reporter assays and RNA pull-down assays were carried out to study the mechanism by which PCGEM1 regulates ANTXR2. Results: Our results indicated that PCGEM1 promoted the motility and proliferation of ectopic endometrial cells, and the underlying mechanism was due to the direct binding of PCGEM1 to miR-124-3p to modulate ANTXR2 expression. Conclusion: PCGEM1 can influence endometrial stromal cell proliferation and motility and may be a novel therapeutic target for endometriosis.
- Open Access
- 25 July 2022
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 101 (10) , 1074-1084
Integrated bioinformatic analysis of dysregulated microRNA‐mRNA co‐expression network in ovarian endometriosis
Introduction: Ovarian endometriosis is a frequently occurring gynecological disease with large socioeconomic impact. Accumulating evidence has suggested that aberrant miRNA‐mRNA interactions are involved in the pathogenesis and progression of ovarian endometriosis. This study aims to identify key miRNAs in ovarian endometriosis by using integrated bioinformatic analysis of a dysregulated miRNA‐mRNA co‐expression network.Material and methods: Expression profiling of miRNA and mRNA in three normal endometria and five pairs of ectopic/eutopic endometria from patients with ovarian endometriosis was determined by high‐throughput sequencing techniques. The data were then integrated with the public sequencing datasets (GSE105764 and GSE105765) using a non‐biased approach and a miRNA‐mRNA co‐expression regulatory network was constructed by in‐depth bioinformatic analysis.Results: The constructed miRNA‐mRNA network included 87 functionally DEMs, 482 target mRNAs and 1850 paired miRNA‐mRNA regulatory interactions. Specifically, five miRNAs (miR‐141‐3p, miR‐363‐3p, miR‐577, miR‐767‐5p, miR‐96‐5p) were gradually decreased and two miRNAs (miR‐493‐5p, miR‐592) were gradually increased from normal endometria to eutopic endometria, and then ectopic endometria tissues. Importantly, miR‐141‐3p, miR‐363‐3p and miR‐96‐5p belonged to the miR‐200 family, miR‐106a‐363 cluster and miR‐183/96/182 cluster, respectively. Their target mRNAs were mainly associated with cell adhesion, locomotion and binding, which are suggested to play vital regulatory roles in the pathogenesis of ovarian endometriosis.Conclusions: Integrated bioinformatic analysis of the miRNA‐mRNA co‐expression network defines the crucial roles of the miR‐200 family, miR‐106a‐363 cluster and miR‐183/96/182 cluster in the pathogenesis of ovarian endometriosis. Further in‐depth functional studies are needed to unveil the molecular mechanisms of these miRNAs, and may provide clues for the optimization of therapeutic strategies for ovarian endometriosis.
- 25 July 2022
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 101 (10) , 1074-1084
Open AccessIntegrated bioinformatic analysis of dysregulated microRNA‐mRNA co‐expression network in ovarian endometriosis
Introduction: Ovarian endometriosis is a frequently occurring gynecological disease with large socioeconomic impact. Accumulating evidence has suggested that aberrant miRNA‐mRNA interactions are involved in the pathogenesis and progression of ovarian endometriosis. This study aims to identify key miRNAs in ovarian endometriosis by using integrated bioinformatic analysis of a dysregulated miRNA‐mRNA co‐expression network.Material and methods: Expression profiling of miRNA and mRNA in three normal endometria and five pairs of ectopic/eutopic endometria from patients with ovarian endometriosis was determined by high‐throughput sequencing techniques. The data were then integrated with the public sequencing datasets (GSE105764 and GSE105765) using a non‐biased approach and a miRNA‐mRNA co‐expression regulatory network was constructed by in‐depth bioinformatic analysis.Results: The constructed miRNA‐mRNA network included 87 functionally DEMs, 482 target mRNAs and 1850 paired miRNA‐mRNA regulatory interactions. Specifically, five miRNAs (miR‐141‐3p, miR‐363‐3p, miR‐577, miR‐767‐5p, miR‐96‐5p) were gradually decreased and two miRNAs (miR‐493‐5p, miR‐592) were gradually increased from normal endometria to eutopic endometria, and then ectopic endometria tissues. Importantly, miR‐141‐3p, miR‐363‐3p and miR‐96‐5p belonged to the miR‐200 family, miR‐106a‐363 cluster and miR‐183/96/182 cluster, respectively. Their target mRNAs were mainly associated with cell adhesion, locomotion and binding, which are suggested to play vital regulatory roles in the pathogenesis of ovarian endometriosis.Conclusions: Integrated bioinformatic analysis of the miRNA‐mRNA co‐expression network defines the crucial roles of the miR‐200 family, miR‐106a‐363 cluster and miR‐183/96/182 cluster in the pathogenesis of ovarian endometriosis. Further in‐depth functional studies are needed to unveil the molecular mechanisms of these miRNAs, and may provide clues for the optimization of therapeutic strategies for ovarian endometriosis.
- 5 March 2020
- Published by Springer Nature
- p. 187-194
Demand Forecasting of Helicopter Aviation Materials Based on Multi-model Reliability Analysis
- 5 March 2020
- Published by Springer Nature
- p. 187-194
Demand Forecasting of Helicopter Aviation Materials Based on Multi-model Reliability Analysis
- 1 May 2019
- Published by Elsevier in Clinical Lung Cancer
- Vol. 20 (3) , e229-e232
Case Report: Temporal Heterogeneity of ALK Activating Mutations in Sequential ALK TKI–Treated Non–Small-Cell Lung Cancer Revealed Using NGS-Based Liquid Biopsy
- 1 May 2019
- Published by Elsevier in Clinical Lung Cancer
- Vol. 20 (3) , e229-e232
Case Report: Temporal Heterogeneity of ALK Activating Mutations in Sequential ALK TKI–Treated Non–Small-Cell Lung Cancer Revealed Using NGS-Based Liquid Biopsy
- Open Access
- 1 March 2018
- Published by Wolters Kluwer Health in Medicine
- Vol. 97 (12) , e0090
Primary cervical ganglioneuroblastoma
Ganglioneuroblastoma is usually located in the adrenal gland, retroperitoneal ganglia, or posterior mediastinum, but rarely occurs in the parapharyngeal space. A 4-year-old girl presented with complaint of progressive inspiratory dyspnea and dysphagia, accompanying left-side Horner's syndrome. Computed tomography (CT) scan revealed a giant mass with irregular low density in left oropharyngeal and posterior pharyngeal wall. The left carotid artery sheath was pushed to the right. After enhancement, the central part of the mass was strengthened, and the surrounding bones structures appeard normal. Magnetic resonance imaging (MRI) showed a solid mass in the left parapharyngeal space displacing the left carotid sheath posteriorly and laterally. A ganglioneuroblastoma was diagnosed. The girl was treated by surgery. The postoperative course was uneventful. There was no recurrence was observed during the 1-year follow-up. The primary cervical ganglioneuroblastoma is rare, we recommended the ganglioneuroblastoma should be considered in the differential diagnosis of a child presenting with a parapharyngeal space mass.
- 1 March 2018
- Published by Wolters Kluwer Health in Medicine
- Vol. 97 (12) , e0090
Open AccessPrimary cervical ganglioneuroblastoma
Ganglioneuroblastoma is usually located in the adrenal gland, retroperitoneal ganglia, or posterior mediastinum, but rarely occurs in the parapharyngeal space. A 4-year-old girl presented with complaint of progressive inspiratory dyspnea and dysphagia, accompanying left-side Horner's syndrome. Computed tomography (CT) scan revealed a giant mass with irregular low density in left oropharyngeal and posterior pharyngeal wall. The left carotid artery sheath was pushed to the right. After enhancement, the central part of the mass was strengthened, and the surrounding bones structures appeard normal. Magnetic resonance imaging (MRI) showed a solid mass in the left parapharyngeal space displacing the left carotid sheath posteriorly and laterally. A ganglioneuroblastoma was diagnosed. The girl was treated by surgery. The postoperative course was uneventful. There was no recurrence was observed during the 1-year follow-up. The primary cervical ganglioneuroblastoma is rare, we recommended the ganglioneuroblastoma should be considered in the differential diagnosis of a child presenting with a parapharyngeal space mass.